Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine

Home Conoscenze Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine

Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine


These two studies were aimed to evaluate the efficacy of ERAVAC® in naïve rabbits up to 6 months after immunization, although protection for a longer period of time (up to 12 month) as an aid to establish the most adequate prevention program for the disease was also explored.

Informazioni sull'articolo

Pubblicato in

SVEPM Conference, 2018

Data

18 mag 2018

Autori

Sánchez-Matamoros, A.; Boix, O.; Ruiz, M. C.; Woodward, M.; Maldonado, J.

Riepilogo

This study demonstrates the following: • RHDV-2 vaccine stimulates the humoral response at 7 dpv, inducing high and long lasting antibody titers up to 12 mpv. • RHDV-2 vaccine confers protective immunity to virulent heterologous challenge. • A RHDV-2 prevention program could be based on a vaccination interval of at least 12 months.

Servizi correlati

Prodotti correlati

Condividi